中文名称: IL-1 ALPHA/IL-1A, RAT, 重组蛋白 中文同义词: IL-1 ALPHA/IL-1A, RAT, 重组蛋白 英文名称: IL-1 alpha/IL-1A Protein, Rat, Recombinant 英文同义词: IL-1 alpha/IL-1A Protein, Rat, Recombinant CAS号: 分子式: 分子量: 0 EINECS号: 信息错误报告 您的Email: 按国家浏览IL-...
英文名Recombinant Human Interleukin-1 alpha 别名IL-1α, Human 相关类别细胞因子储存冷冻(-20℃) 分子量Approximately 18.0 kDa, a single non-glycosylated polypeptide chain containing 159 amino acids. 编 号包装库存目录价(¥)您的价格(¥)数量
英文名称: Recombinant Rat IL-1 alpha/IL-1F1/IL-1α/IL-1a/Interleukin-1 Alpha 英文同义词: CAS号: 分子式: 分子量: 0 EINECS号: Mol文件: Mol File RECOMBINANT RAT IL-1 ALPHA/IL-1F1/IL-1Α/IL-1A/INTERLEUKIN-1 ALPHA 信息错误报告 提交 按省份浏览RECOMBINANT RAT IL-1 ALPHA/IL-...
人源细胞表达的重组人白介素-1 α蛋白产品,又称IL1A, IL-1A, IL1, IL1-ALPHA, IL1ALPHA, IL1F1, IL-1α, IL1α, Interleukin-1 alpha, Interleukin-1, Interleukin.其对应NCBI基因号为3552,对应Accession号为P01583. 来源宿主 提供的【IL 1a】人源细胞表达的重组人白介素-1 α产品的来源为人胚胎肾...
上海玉博生物科技有限公司 主要致力于“Recombinant Human IL-1alpha 500 ug eBioscience-34-8019-85”的生产销售。多年的“Recombinant Human IL-1alpha 500 ug eBioscience-34-8019-85”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名称深
商品属性: 货号 产品名称 规格 价格 P-Db1752 Recombinant Mouse IL-1 alpha 50μg 4440 P-Db1752 Recombinant Mouse IL-1 alpha 200ug 8100 P-Db1752 Recombinant Mouse IL-1 alpha 1mg 25920 商品介绍: 产品名称
IL-1 alpha recombinant protein Cited in 1 papers. Free of endotoxin and animal components. Authentic glycosylation, maturation, and folding lead to greater stability and activity than CHO and E. coli systems.
亚型: IgG1 是否单克隆: 是 免疫原: NA 保质期: 1 year 标记物: Unconjugate 包装规格: 100ug 抗原来源: NA 适应物种: Human 克隆性: 是 标识物: Unconjugate 形态: Liquid 保存条件: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (...
NOD mice usually die within 1 to 2 months after the onset of diabetes unless they receive insulin therapy. Chemically induced diabetes is accomplished using multiple injections of small doses of streptozotocin, a drug toxic for pancreatic β cells, which causes severe insulitis and diabetes (see...
IL-2 administration. This study demonstrates that (a) intermittent i.v. bolus IL-2 therapy can generate LAK activity, (b) LAK activity may be associated with an antitumor response, (c) significant levels of gamma-interferon are induced by this therapy, and (d) IL-2 and IFN-beta given ...